Rationale kombination für die asthmatherapie salmeterol und fluticason in einem präparat

Pneumologie

Volumn 53, Issue 9, 1999, Pages 426-432

  Wettengel, R ^a   Steinkamp, G ^a  

^a Karl Hansen Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANE DERIVATIVE; ANTIASTHMATIC AGENT; BRONCHODILATING AGENT; DRUG DERIVATIVE; FLUTICASONE; SALBUTAMOL; SALMETEROL;

ASTHMA; DRUG COMBINATION; HUMAN; REVIEW;

ALBUTEROL; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHODILATOR AGENTS; DRUG COMBINATIONS; HUMANS;

EID: 0033195567     PISSN: 09348387     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-9034     Document Type: Article

References (38)

1. Literatur 1 Baker J, Yancey S, Kalberg C, Petrocella V, Emmett A, Bowers B, Rickard K. Added salmeterol versus increased-dose fluticasone in patients symptomatic on low-dose fluticasone. Am J Respir Crit Care Med 1998; 157:406
2. Barnes PJ, Godfrey S, Magnussen H. Asthma bronchiale. London: Martin Dunitz Ltd., 1997
3. Bateman ED, Britton M, Carrillo J, Almeida J, Wixon C. Salmeterol/fluticason combination inhaler. Clin Drug Invest 1998; 16: 193-201
4. Buhl R, Kardos P, Magnussen H, Matthys H, Sauer R, Schauer P, Vogelmeier C, Wettengel R, Worth H, Menz G. Feste Kombination inhalierbarer Kortikoide und langwirkender ß2-Sympathomimetika zur Langzeittherapie des Asthma bronchiale. Pneumologie 1999:53:210-212
5. Campbell DA, McLennan G, Coates JR. Frith PA, Gluyas PA, Latimer KM, Luke CG, Martin AJ, Roder DM, Ruffin RE. A comparison of asthma deaths and near-fatal asthma attacks in South Australia. Eur Respir J 1994; 7: 490 - 497
6. Cook D, Srebro SH, Rogenes PR, Rickard K, Edwards L, Johnson MC. A comparison of the safety and efficacy of fluticasone, triamcinolone, and fluticasone plus salmeterol in patients with mild to moderate asthma. Am J Respir Crit Care Med 1998; 157: A416
7. D'Alonzo GE, Tolep KA. Salmeterol in the treatment of chronic asthma. Am Fam Physician 1997; 56: 558 - 562
8. Dahl R. Salmeterol and fluticasone propionate in the treatment of asthma symptoms. Eur Respir Rev 1997; 7:49: 338 - 343
9. Edwards T, Gross G, Mitchell D, Chervinsky P, Woodring A, Baitinger L, Prillaman B, House K, Shah T. The salmeterol xinafoate/fluticasone propionate dry powder combination product via diskus inhaler improves asthma control compared to salmeterol xinafoate or fluticasone propionate dry powder alone. Am J Respir Crit Care Med 1998; 157: A414
10. Gerrits CMJM, Herings RMC, Lammers JWJ, Leufkens HGM. Too low usage of inhaled steroids among patients with long-acting ß2-agonists. Eur Respir J1998; 12:156s, P1106
11. Glaxo Wellcome. Study SFCA 3003: Salmeterol/fluticasone combination product (50/250) improves asthma control (Data on file). 1998
12. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 219 224
13. Gross G, Woodring A, Prillaman B, House K, Shah T. Efficacy and safety of the salmeterol/fluticasone propionate (50/100 u.g) dry powder combination inhaler in patients with asthma. Eur Respir J 1998; 12: 156s, P1104
14. Ind PW, Negro dal R, Fletcher CP, Browning DC, James MH. Inhaled salmeterol and fluticasone propionate therapy in moderate adult asthma. Eur Respir J 1997; 10: Is, P0149
15. Janson C, Chinn S, Jarvis D, Burney P. Physician-diagnosed asthma and drug utilization in the European Community Respiratory Health Survey. Eur Respir J 1997; 10: 1795 - 1802
16. Johansson H, Mclvor RA, Purello F, D'Ambrosio C, Gratziou C, James MH. Salmeterol/fluticasone propionate combination dry powder inhaler (50/100 fig BID) is more effective than budesonide (400 \ag BID) in mild to moderate asthma. Eur Respir J 1998; 12: P162
17. Johansson LO. A comparison of once-daily of fluticasone propionate (FP) 200 ug and budesonide (BUD) 400 jig twice-daily. Am J Respir Crit Care Med 1998; 157: A404
18. Mann MC, Eliasson 0, Patel K, ZuWallack RL An evaluatin of severity-modulated compliance with q.i.d. dosing of inhaled beclomethasone. Chest 1992; 102: 1342 - 1346
19. Muir JF, Bertin L, Georges D. Salmeterol versus slow-release theophylline combined with ketotifen in nocturnal asthma: a multicentre trial. French Multicentre Study Group. Eur Respir J 1992:5:1197-1200
20. National Heart, L a. B. I., WHO. Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report 1995; Publ. No.: 95-3659
21. Nowak D, Volmer T, Wettengel R. Asthma bronchiale - eine Krankheitskostenanalyse. Pneumologie 1996; 50: 364-371
22. Nutini S, Martini T, Righi R. Long-term treatment of asthmatic patients with salmeterol vs slow-release theophylline. Respir Med 1998; 92: 683-690
23. Paggiaro PL, Giannini D, Franco Di A, Testi R. Comparison of inhaled salmeterol and individually dose-titrated slow-release theophylline in patients with reversible airway obstruction European Study Group. Eur Respir J 1996; 9:1689 - 1695
24. Pauwels RA, Lofdahl CG, Postma DS, Tattersfield AE, O'Byrne P, Barnes PJ, Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N Engl J Med 1997; 337: 1405 - 1411
25. Pieters WR, Ringdal N, Aubier M, Chapman K, Huskisson SC. A new inhaler combination containing salmeterol and fluticasone propionate is well-tolerated in longterm use. Eur Respir J 1998; 12: 20s, PI64
26. Pieters WR, Steinmetz KO, Aubier M, Johnson L, Gomez E, Bogolubov M. Effectiveness of a new salmeterol/fluticasone propionate (50/500 ug) combination inhaler in patients with reversible airways obstruction. Eur Respir J 1998; 12: 35s, P0329
27. Pollard SJ, Spector SL, Yancey SW, Cox FM, Emmett A. Salmeterol versus theophylline in the treatment of asthma. Ann Allergy Asthma Immunol 1997; 78: 457-464
28. Reese PR, Mahajan P, Woodring A. Salmeterol/fluticasone propionate combination product improves quality of life in asthma patients. Eur Respir J 1998; 12: 35s, P0325
29. Ringdal N, Chapman KR, Backer V, Palmqvist M, Saarelainen S, Briggs M. Asthma control with salmeterol and fluticasone propionate (50/250 jig) given twice daily in a single combination Diskus™(Accuhaler™) inhaler compared to salmeterol 50 jig and fluticasone propionate 250 u.g given twice daily via two separate Diskus inhalers. Eur Respir J 1998; 12: 36s, P0330
30. Schlosser NJJ, Steinmetz KO, Aubier M, Gomez E, Wixon C. Evaluation of longterm safety of salmeterol/fluticasone propionate (50/500 ug) combination inhaler in patients with reversible airways obstruction. Eur Respir J 1998; 12: 3s, P0343
31. Schultze-Werninghaus G. Neue Erkenntnisse zu allergisch bedingten Atemwegserkrankungen. Deutsches Ärzteblatt 1997; 94:A-523-A-528
32. Selroos 0. The pharmacologie and clinical properties of Oxis (formoterol) Turbuhaler. Allergy 1998; 53: 14-19
33. Ukena D, Köper I, Braun H, Leutz M, Schlimmer P, Sybrecht GW. Therapy of nocturnal asthma: salmeterol versus nocturnal administration of retard theophylline-comparison of effectiveness and tolerance. Pneumologie 1997; 51: 317 - 323
34. Berg Van Den NJ, Ossip M, Hederos CA, Anttila H, Davies P. Combination salmeterol xinafoate and fluticasone propionate (50/100 jig strength) bd via one DiskusTM (Accuhaler TM) inhaler compared with salmeterol xinafoate 50u,g and fluticasone propionate 100 u,g bd via two separate diskus inhalers. Eur Respir J 1998; 12: 157s, P1108
35. Noord van JA, Schreurs AJM, Mulders PGH, Mol SJM. Comparison of the efficacy of doubling the dose fluticasone propionate (FP) and adding salmeterol (SLM) in patients with mild-to-moderate asthma. Am JRespirCrit Care Med 1997; 155: 100s
36. Mutius von E, Weiland SK, Fritzsch C, Duhme H, Keil U. Increasing prevalence of hay fever and atopy among children in Leipzig, East Germany. Lancet 1998; 351: 862 - 866
37. Wettengel R, Berdel D, Hofmann D, Krause J, Kroegel C, Kroidl RF, Leupold W, Lindemann H, Magnussen H, Meister R et al.. Empfehlungen zur Asthmatherapie bei Kindern und Erwachsenen. Pneumologie 1998; 52: 591 -601
38. Woolcock A, Lundback B, Ringdal N, Jacques LA. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 153: 1481 -1488